These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 517052)

  • 1. Serum tissue concentrations of immunoreactive calcitonin in patients with breast tumours.
    Jørgensen OG; Ekeland A; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):522-31. PubMed ID: 517052
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoreactive serum calcitonin in breast cancer].
    Fereberger W; Leb G; Passath A; Samonigg H; Beaufort F
    MMW Munch Med Wochenschr; 1982 May; 124(19):471-2. PubMed ID: 6810110
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcitonin. III. Use of serum calcitonin as a tumor marker in breast and pulmonary neoplasms].
    Gadesberg CC; Nielsen HE; Olsen KJ; Hansen HH
    Ugeskr Laeger; 1979 Oct; 141(40):2744-6. PubMed ID: 531963
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcitonin and mammary carcinoma.
    Wählby L; Westman G
    Acta Radiol Oncol; 1980; 19(4):251-3. PubMed ID: 6257046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocalcemia and an inappropriate endocrine response in osteoblastic metastatic breast cancer.
    Bouvier DP
    South Med J; 1989 Dec; 82(12):1574-6. PubMed ID: 2556799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum calcitonin in patients with mammary carcinoma.
    Olsen KJ; Gadeberg C; Nielsen HE; Johannsen A
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(4):263-8. PubMed ID: 717039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of immunoreactive calcitonin by human breast carcinomas.
    Coombes RC; Easty GC; Detre SI; Hillyard CJ; Stevens U; Girgis SI; Galante LS; Heywood L; Macintyre I; Neville AM
    Br Med J; 1975 Oct; 4(5990):197-9. PubMed ID: 1191996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia and status epilepticus relates to salmon calcitonin administration in breast cancer.
    Chung SY; Chen TH; Lai SL; Huang CH; Chen WH
    Breast; 2005 Oct; 14(5):399-402. PubMed ID: 16143533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Plasma-calcitonin and non-thyroid tumours.
    Greenfield B
    Lancet; 1974 Jul; 2(7873):164. PubMed ID: 4135563
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin not a cellular tumour marker in breast cancer.
    Bulman AS; Heyderman E
    Lancet; 1983 Feb; 1(8320):351. PubMed ID: 6130347
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium metabolism in cancer. Studies using calcium isotopes and immunoassays for parathyroid hormone and calcitonin.
    Coombes RS; Ward MK; Greenberg PB; Hillyard CJ; Tulloch BR; Morrison R; Joplin GF
    Cancer; 1976 Nov; 38(5):2111-20. PubMed ID: 186180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases.
    Henderson M; Danks J; Moseley J; Slavin J; Harris T; McKinlay M; Hopper J; Martin T
    J Natl Cancer Inst; 2001 Feb; 93(3):234-7. PubMed ID: 11158193
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
    BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of calcitonin and parathyrin in blood serum in the diagnosis of tumor metastases to bone].
    Smirnov IuN
    Med Radiol (Mosk); 1986 Apr; 31(4):9-12. PubMed ID: 3959820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive calcitonin in brain regions and pituitary of sheep.
    Balabanova S; King O; Nowak R; Sachs H; Leupold D
    J Endocrinol Invest; 1985 Oct; 8(5):409-15. PubMed ID: 2867111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is baseline bone imaging in high-risk breast cancer patients justified?
    Ampil FL; Li BD; Burton GV; Kim RH; Baluna RG; Chu Q
    Breast J; 2012; 18(6):639-40. PubMed ID: 23009654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
    Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
    Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis for bone metastasis of breast cancer based on bone metabolism.
    Suzuki S
    Fukushima J Med Sci; 1990 Jun; 36(1):11-27. PubMed ID: 2102478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biochemical approach to the staging of human breast cancer.
    Coombes RC; Powles TJ; Gazet JC; Ford HT; Nash AG; Sloane JP; Hillyard CJ; Thomas P; Keyser JW; Marcus D; Zinberg N; Stimson WH; Neville AM
    Cancer; 1977 Aug; 40(2):937-44. PubMed ID: 890676
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal surveillance for postoperative metastasis in breast cancer patients.
    Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
    Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.